In addition, the first evidence that Arg1 present in RBCs can modulate endothelial dysfunction and the outcome of I/R injury has come from bioassays (Yang et al, 2018; Zhou et al, 2018; Mahdi et al, 2020b). This evidence concerns the gene ARG1 and endothelial dysfunction.